-
1
المؤلفون: Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D’Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D'Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele, Breccia, M, Martino, B, D'Adda, M, Stagno, F, Carella, Am, Avanzini, P, Tiribelli, M, Trabacchi, E, Visani, G, Gobbi, M, Salvucci, M, Levato, L, Binotto, G, Capalbo, Sf, Bochicchio, MARIA TERESA, Alimena, G, Pane, F, Saglio, G
المصدر: Haematologica. 101:1200-1207
مصطلحات موضوعية: Blood Glucose, Myeloid, Male, 030204 cardiovascular system & hematology, Gastroenterology, chemistry.chemical_compound, 0302 clinical medicine, High-density lipoprotein, 80 and over, Chronic Myelogenous Leukemia, Aged, 80 and over, Leukemia, Hematology, Incidence (epidemiology), Remission Induction, Myeloid leukemia, Articles, Middle Aged, Cholesterol, Treatment Outcome, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Female, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Molecular response, Young Adult, 03 medical and health sciences, Aged, Humans, Protein Kinase Inhibitors, Pyrimidines, Thrombosis, Triglycerides, chronic myeloid leukemia, Internal medicine, medicine, Adverse effect, Tyrosine kinase inhibitors, business.industry, Nilotinib, Discontinuation, Surgery, chemistry, Arterial Thrombosi, Chronic-Phase, Glycated hemoglobin, business
وصف الملف: ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67aede7eee197508237e3d43548b0ec5
https://doi.org/10.3324/haematol.2016.144949 -
2
المؤلفون: Palandri, Francesca, Iacobucci, Ilaria, Castagnetti, Fausto, Testoni, Nicoletta, Poerio, Angela, Amabile, Marilina, Breccia, Massimo, Intermesoli, Tamara, Iuliano, Francesco, Rege Cambrin, Giovanna, Tiribelli, Mario, Miglino, Maurizio, Pane, Fabrizio, Saglio, Giuseppe, Martinelli, Giovanni, Rosti, Gianantonio, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T, Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M, GIMEMA Working Party on CML., Francesca, Palandri, Ilaria, Iacobucci, Fausto, Castagnetti, Nicoletta, Testoni, Angela, Poerio, Marilina, Amabile, Massimo, Breccia, Tamara, Intermesoli, Francesco, Iuliano, Giovanna Rege, Cambrin, Mario, Tiribelli, Maurizio, Miglino, Pane, Fabrizio, Giuseppe, Saglio, Giovanni, Martinelli, Gianantonio, Rosti, Michele, Baccarani, G. I., M.
المصدر: Haematologica. 93:770-774
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Phases of clinical research, Alpha interferon, IMATINIB, Disease-Free Survival, Piperazines, Cohort Studies, Chronic myeloid leukemia, Imatinib, Interferon-alpha, Long-term results, Antineoplastic Combined Chemotherapy Protocols, Benzamides, Cytogenetics, Follow-Up Studies, Humans, Imatinib Mesylate, Immunologic Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Patient Compliance, Pyrimidines, Treatment Outcome, Hematology, Pegylated interferon, Internal medicine, medicine, Chronic, Interferon alfa, CHRONIC MYELOID LEUKEMIA, Leukemia, business.industry, Myeloid leukemia, medicine.disease, Imatinib mesylate, Immunology, BCR-ABL Positive, business, Myelogenous, medicine.drug, Chronic myelogenous leukemia
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89ef090eb4fe1036e211b13f1f49aca
https://doi.org/10.3324/haematol.12265 -
3
المؤلفون: Luatti, Simona, Castagnetti, Fausto, Marzocchi, Giulia, Baldazzi, Carmen, Gugliotta, Gabriele, Iacobucci, Ilaria, Specchia, Giorgina, Zanatta, Lucia, Rege Cambrin, Giovanna, Mancini, Marco, Abruzzese, Elisabetta, Zaccaria, Alfonso, Grimoldi, Maria Grazia, Gozzetti, Alessandro, Ameli, Gaia, Capucci, Maria Adele, Palka, Giandomenico, Bernasconi, Paolo, Palandri, Francesca, Pane, Fabrizio, Saglio, Giuseppe, Martinelli, Giovanni, Rosti, Gianantonio, Baccarani, Michele, Testoni, Nicoletta, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: S Luatti, F Castagnetti, G Marzocchi, C Baldazzi, G Gugliotta, I Iacobucci, G Specchia, L Zanatta, G Rege-Cambrin, M Mancini, E Abruzzese, A Zaccaria, M G Grimoldi, A Gozzetti, G Ameli, M A Capucci, G Palka, P Bernasconi, F Palandri, F Pane, G Saglio, G Martinelli, G Rosti, M Baccarani, N Testoni, on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML
مصطلحات موضوعية: Oncology, Myeloid, Male, Messenger, Biochemistry, Piperazines, Additional chromosomal abnormalities (ACA), European LeukemiaNet, hemic and lymphatic diseases, 80 and over, Medicine, Philadelphia Chromosome, Prospective Studies, Prospective cohort study, In Situ Hybridization, Fluorescence, In Situ Hybridization, Aged, 80 and over, Leukemia, Reverse Transcriptase Polymerase Chain Reaction, Hematology, Middle Aged, Prognosis, Survival Rate, medicine.anatomical_structure, Leukemia, Myeloid, Chronic-Phase, Benzamides, Cytogenetic Analysis, Imatinib Mesylate, Female, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Immunology, Antineoplastic Agents, Philadelphia chromosome, Real-Time Polymerase Chain Reaction, IMATINIB, Fluorescence, Young Adult, Internal medicine, Humans, RNA, Messenger, Survival rate, Aged, Chromosome Aberrations, business.industry, Imatinib, Cell Biology, PHILADELPHIA-POSITIVE LEUKEMIAS, medicine.disease, Pyrimidines, eye diseases, stomatognathic diseases, Imatinib mesylate, RNA, Chronic-Phase, business, CHRONIC MYELOID LEUKEMIA (CML)
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0182962514a253864e1090aa081e9a6e
http://hdl.handle.net/11585/152802 -
4
المؤلفون: Castagnetti, Fausto, Testoni, Nicoletta, Luatti, Simona, Marzocchi, Giulia, Mancini, Marco, Kerim, Simonetta, Giugliano, Emilia, Albano, Francesco, Cuneo, Antonio, Abruzzese, Elisabetta, Martino, Bruno, Palandri, Francesca, Amabile, Marilina, Iacobucci, Ilaria, Alimena, Giuliana, Pane, Fabrizio, Martinelli, Giovanni, Saglio, Giuseppe, Baccarani, Michele, Rosti, Gianantonio, GIMEMA CML working party, Bocchia, Monica
المساهمون: Castagnetti, F., Testoni, N., Luatti, S., Marzocchi, G., Mancini, M., Kerim, S., Giugliano, E., Albano, F., Cuneo, A., Abruzzese, E., Martino, B., Palandri, F., Amabile, M., Iacobucci, I., Alimena, G., Pane, Fabrizio, Martinelli, G., Saglio, G., Baccarani, M., Rosti, G., Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S, Giugliano E, Albano F, Cuneo A, Abruzzese E, Martino B, Palandri F, Amabile M, Iacobucci I, Alimena G, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G, Castagnetti, F, Testoni, N, Luatti, S, Marzocchi, G, Mancini, M, Kerim, S, Giugliano, E, Albano, F, Cuneo, A, Abruzzese, E, Martino, B, Palandri, F, Amabile, M, Iacobucci, I, Alimena, G, Martinelli, G, Saglio, G, Baccarani, M
مصطلحات موضوعية: Oncology, poor-prognosis, Myeloid, Male, Cancer Research, Kaplan-Meier Estimate, Severity of Illness Index, Piperazines, European LeukemiaNet, fusion gene transcripts, Reference Values, hemic and lymphatic diseases, 80 and over, Prospective Studies, stem-cell transplantation, In Situ Hybridization, In Situ Hybridization, Fluorescence, Aged, 80 and over, Adolescent, Adult, Age Factors, Aged, Benzamides, Chromosomes, Human, Pair 9, Cytogenetic Analysis, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Imatinib Mesylate, Italy, Leukemia, Myeloid, Chronic-Phase, Logistic Models, Maximum Tolerated Dose, Middle Aged, Multivariate Analysis, Probability, Prognosis, Pyrimidines, Reverse Transcriptase Polymerase Chain Reaction, Risk Assessment, Statistics, Nonparametric, Survival Analysis, Treatment Outcome, Young Adult, Gene Deletion, Medicine (all), Leukemia, philadelphia-chromosome, Statistics, Myeloid leukemia, chronic myelogenous leukemia, medicine.anatomical_structure, abl tyrosine kinase, bcr expression, cytogenetic responses, minimal-residual-disease, patients receiving imatinib, Drug, medicine.drug, Human, Pair 9, medicine.medical_specialty, Derivative chromosome, Chromosomes, Fluorescence, Dose-Response Relationship, chronic myeloid leukemia, Internal medicine, medicine, Nonparametric, business.industry, Imatinib, medicine.disease, Imatinib mesylate, Immunology, Chronic-Phase, Bone marrow, business
وصف الملف: ELETTRONICO; STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731620b3d4b33af3c2332aa3fd0d961c
http://hdl.handle.net/11588/371591 -
5
المؤلفون: Castagnetti, Fausto, Palandri, Francesca, Amabile, Marilina, Testoni, Nicoletta, Luatti, Simona, Soverini, Simona, Iacobucci, Ilaria, Breccia, Massimo, Cambrin, Giovanna Rege, Stagno, Fabio, Specchia, Giorgina, Galieni, Piero, Iuliano, Franco, Pane, Fabrizio, Saglio, Giuseppe, Alimena, Giuliana, Martinelli, Giovanni, Baccarani, Michele, Rosti, Gianantonio, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Castagnetti, F, Palandri, F, Amabile, M, Testoni, N, Luatti, S, Soverini, S, Iacobucci, I, Breccia, M, Rege Cambrin, G, Stagno, F, Specchia, G, Galieni, P, Iuliano, F, Pane, Fabrizio, Saglio, G, Alimena, G, Martinelli, G, Baccarani, M, Rosti, G.
المصدر: Blood. 113(15)
مصطلحات موضوعية: Oncology, Male, Biochemistry, Piperazines, Adult, Aged, Antineoplastic Agents, Benzamides, Disease-Free Survival, Female, Follow-Up Studies, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Middle Aged, Patient Compliance, Prospective Studies, Pyrimidines, Risk Factors, Treatment Outcome, Hematology, Cell Biology, Immunology, law.invention, Randomized controlled trial, law, hemic and lymphatic diseases, Chronic, Leukemia, Myeloid leukemia, Tolerability, Sokal Score, medicine.drug, medicine.medical_specialty, Adult, Aged, Antineoplastic Agents, administration /&/ dosage/adverse effects, Disease-Free Survival, Female, Follow-Up Studies, Humans, Leukemia, Myelogenous, BCR-ABL Positive, drug therapy/epidemiology, Male, Middle Aged, Patient Compliance, Piperazines, administration /&/ dosage/adverse effects, Prospective Studies, Pyrimidines, administration /&/ dosage/adverse effects, Risk Factors, Treatment Outcome, administration /&/ dosage/adverse effects, Internal medicine, medicine, business.industry, Imatinib, medicine.disease, drug therapy/epidemiology, Surgery, Clinical trial, Imatinib mesylate, business, Chronic myelogenous leukemia
وصف الملف: ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8544d0156519bfe1b31f42723dae22fc
https://pubmed.ncbi.nlm.nih.gov/19211938 -
6
المؤلفون: Rosti, Gianantonio, Palandri, Francesca, Castagnetti, Fausto, Breccia, Massimo, Levato, Luciano, Gugliotta, Gabriele, Capucci, Adele, Cedrone, Michele, Fava, Carmen, Intermesoli, Tamara, Cambrin, Giovanna Rege, Stagno, Fabio, Tiribelli, Mario, Amabile, Marilina, Luatti, Simona, Poerio, Angela, Soverini, Simona, Testoni, Nicoletta, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Rosti G, Palandri F, Castagnetti F, Breccia M, Levato L, Gugliotta G, Capucci A, Cedrone M, Fava C, Intermesoli T, Cambrin GR, Stagno F, Tiribelli M, Amabile M, Luatti S, Poerio A, Soverini S, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, GIMEMA CML Working Party., Rosti, G, Palandri, F, Castagnetti, F, Breccia, M, Levato, L, Gugliotta, G, Capucci, A, Cedrone, M, Fava, C, Intermesoli, T, Rege Cambrin, G, Stagno, F, Tiribelli, M, Amabile, M, Luatti, S, Poerio, A, Soverini, S, Testoni, N, Martinelli, G, Alimena, G, Pane, Fabrizio, Saglio, G, Baccarani, M.
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Aged, Aged, 80 and over, Antineoplastic Agents, Female, Fusion Proteins, bcr-abl, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Middle Aged, Pyrimidines, Treatment Outcome, Young Adult, Hematology, Biochemistry, Cell Biology, Immunology, medicine.drug_class, bcr-abl, NILOTINIB, Phases of clinical research, Gastroenterology, Tyrosine-kinase inhibitor, Internal medicine, hemic and lymphatic diseases, medicine, 80 and over, Chronic, CHRONIC MYELOID LEUKEMIA, Leukemia, business.industry, Myeloid leukemia, Fusion Proteins, Imatinib, medicine.disease, Surgery, Nilotinib, BCR-ABL Positive, business, Chronic myelogenous leukemia, medicine.drug, Myelogenous
وصف الملف: STAMPA; ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9122900d3e2958a4eb1f3019dac6f75a
http://hdl.handle.net/11585/84110 -
7
المؤلفون: Palandri, Francesca, Castagnetti, Fausto, Alimena, Giuliana, Testoni, Nicoletta, Breccia, Massimo, Luatti, Simona, Rege Cambrin, Giovanna, Stagno, Fabio, Specchia, Giorgina, Martino, Bruno, Levato, Luciano, Merante, Serena, Liberati, Anna Maria, Pane, Fabrizio, Saglio, Giuseppe, Alberti, Daniele, Martinelli, Giovanni, Baccarani, Michele, Rosti, Gianantonio, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Francesca, Palandri, Fausto, Castagnetti, Giuliana, Alimena, Nicoletta, Testoni, Massimo, Breccia, Simona, Luatti, Giovanna Rege, Cambrin, Fabio, Stagno, Giorgina, Specchia, Bruno, Martino, Luciano, Levato, Serena, Merante, Anna Maria, Liberati, Pane, Fabrizio, Giuseppe, Saglio, Daniele, Alberti, Giovanni, Martinelli, Michele, Baccarani, Gianantonio, Rosti, Palandri, F, Castagnetti, F, Alimena, G, Testoni, N, Breccia, M, Luatti, S, Rege Cambrin, G, Stagno, F, Specchia, G, Martino, B, Levato, L, Merante, S, Liberati, Am, Saglio, G, Alberti, D, Martinelli, G, Baccarani, M, Rosti, G., Palandri F, Castagnetti F, Alimena G, Testoni N, Breccia M, Luatti S, Rege-Cambrin G, Stagno F, Specchia G, Martino B, Levato L, Merante S, Liberati AM, Pane F, Saglio G, Alberti D, Martinelli G, Baccarani M, Rosti G.
مصطلحات موضوعية: Oncology, Myeloid, Male, imatinib KeyWords Plus:CHRONIC MYELOGENOUS LEUKEMIA, ABL TYROSINE KINASE, PHILADELPHIA-CHROMOSOME, long-term results, Tyrosine-kinase inhibitor, Piperazines, accelerated phase, hemic and lymphatic diseases, 80 and over, Leukemia, INHIBITOR, Myeloid leukemia, Hematology, Middle Aged, chronic myeloid leukemia, imatinib, Survival Rate, Treatment Outcome, Benzamides, Cytogenetic Analysis, Imatinib Mesylate, Female, Complete Hematologic Response, medicine.drug, Adult, medicine.medical_specialty, medicine.drug_class, Author Keywords:chronic myeloid leukemia, CHRONIC GRANULOCYTIC LEUKEMIA, ACUTE LYMPHOBLASTIC-LEUKEMIA, STEM-CELL TRANSPLANTATION, INTERFERON-ALPHA, BLAST CRISIS, MESYLATE, Internal medicine, Multicenter trial, medicine, Humans, Survival rate, Aged, business.industry, Accelerated phase, Chronic myeloid leukemia, Imatinib, Long-term results, Aged, 80 and over, Follow-Up Studies, Leukemia, Myeloid, Accelerated Phase, Pyrimidines, Original Articles, medicine.disease, Surgery, Imatinib mesylate, business, Chronic myelogenous leukemia
وصف الملف: STAMPA; ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca59aad2046b936bf717a921eb03e02e
http://hdl.handle.net/11573/32508 -
8
المؤلفون: Palandri, Francesca, Iacobucci, Ilaria, Martinelli, Giovanni, Amabile, Marilina, Poerio, Angela, Testoni, Nicoletta, Soverini, Simona, Castagnetti, Fausto, De Vivo, Antonio, Breccia, Massimo, Specchia, Giorgina, Abruzzese, Elisabetta, Martino, Bruno, Cilloni, Daniela, Saglio, Giuseppe, Pane, Fabrizio, Liberati, Anna Marina, Rosti, Gianantonio, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Francesca, Palandri, Ilaria, Iacobucci, Giovanni, Martinelli, Marilina, Amabile, Angela, Poerio, Nicoletta, Testoni, Simona, Soverini, Fausto, Castagnetti, Antonio De, Vivo, Massimo, Breccia, Giorgina, Specchia, Elisabetta, Abruzzese, Bruno, Martino, Daniela, Cilloni, Giuseppe, Saglio, Pane, Fabrizio, Anna Marina, Liberati, Gianantonio, Rosti, Michele, Baccarani, G. I., M., Palandri F, Iacobucci I, Martinelli G, Amabile M, Poerio A, Testoni N, Soverini S, Castagnetti F, De Vivo A, Breccia M, Specchia G, Abruzzese E, Martino B, Cilloni D, Saglio G, Pane F, Liberati AM, Rosti G, Baccarani M, GIMEMA Working Party on CML.
مصطلحات موضوعية: Male, Cancer Research, Time Factors, Messenger, Drug Resistance, Fusion Proteins, bcr-abl, Gastroenterology, Piperazines, 80 and over, FAILURE, Prospective Studies, RNA, Neoplasm, Chronic, Prospective cohort study, Proto-Oncogene Proteins c-abl, BCR-ABL, MOLECULAR RESPONSE, Aged, 80 and over, Leukemia, CHRONIC MYELOGENOUS LEUKEMIA, Myeloid leukemia, Middle Aged, Prognosis, Survival Rate, Treatment Outcome, Oncology, Cohort, Benzamides, Proto-Oncogene Proteins c-bcr, Imatinib Mesylate, Female, medicine.drug, MESYLATE THERAPY, FOLLOW-UP, INTERFERON-ALPHA, SURVIVAL BENEFIT, BLAST CRISIS, MANAGEMENT, Adult, medicine.medical_specialty, Alpha interferon, Antineoplastic Agents, Aged, Drug Resistance, Neoplasm, Humans, Interferon-alpha, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Pyrimidines, RNA, Messenger, COMPLETE CYTOGENETIC RESPONDERS (CCR), Internal medicine, medicine, IMATINIB MESYLATE (IM), Survival rate, business.industry, LATE CHRONIC PHASE (LCP), Fusion Proteins, Imatinib, medicine.disease, Surgery, Imatinib mesylate, Neoplasm, RNA, BCR-ABL Positive, business, Chronic myelogenous leukemia, Myelogenous
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e1101b4618cdc93fb0b9e3368aed16
http://hdl.handle.net/11588/342491 -
9
المؤلفون: Rosti, Gianantonio, Iacobucci, Ilaria, Bassi, Simona, Castagnetti, Fausto, Amabile, Marilina, Cilloni, Daniela, Poerio, Angela, Soverini, Simona, Palandri, Francesca, Rege Cambrin, Giovanna, Iuliano, Franco, Alimena, Giuliana, Latagliata, Roberto, Testoni, Nicoletta, Pane, Fabrizio, Saglio, Giuseppe, Baccarani, Michele, Martinelli, Giovanni, GIMEMA CML Working Party, Bocchia, Monica
المساهمون: Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Rege Cambrin G, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G., Rosti, G, Iacobucci, I, Bassi, S, Castagnetti, F, Amabile, M, Cilloni, D, Poerio, A, Soverini, S, Palandri, F, REGE CAMBRIN, G, Iuliano, F, Alimena, G, Latagliata, R, Testoni, N, Pane, Fabrizio, Saglio, G, Baccarani, M, Martinelli, G.
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Aging, Adolescent, Phases of clinical research, Antineoplastic Agents, Disease-Free Survival, Piperazines, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, medicine, 80 and over, Age Factors, Aged, Aged, 80 and over, Benzamides, Female, Humans, Imatinib Mesylate, Middle Aged, Pyrimidines, Treatment Outcome, Chronic, Adverse effect, Hematology, Leukemia, business.industry, Myeloid leukemia, Imatinib, chronic myeloid leukemia, imatinib, older age, medicine.disease, Surgery, Clinical trial, Imatinib mesylate, BCR-ABL Positive, business, medicine.drug, Myelogenous
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43363f028f1182a9a17b2f57dd4dfec
http://hdl.handle.net/11585/43895 -
10
المؤلفون: Lauria Francesco, Bocchia Monica
المصدر: Chronic Myeloid Leukemia ISBN: 9780429164545
Chronic Myeloid Leukemiaمصطلحات موضوعية: business.industry, medicine.medical_treatment, medicine, Cancer research, Myeloid leukemia, Immunotherapy, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::325031d3100ca7bdac93b75dc0e50689
https://doi.org/10.3109/9780849379567-8